Inventor
YUANZHENG ZHANG
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07KPeptides32%
A61KPreparations for medical, dental or toiletry purposes26%
C12NMicroorganisms or enzymes10%
PatentTitleYear
12,577,310Caninized antibodies to canine interleukin-31 receptor 202612,552,864Caninized antibodies to human CTLA-4202612,545,738Canine interleukin-4 receptor 202612,435,143Caninized antibodies against canine CTLA-4202512,252,536Caninized antibodies202512,221,486Caninized human antibodies to human IL-4R alpha202512,180,288Antibodies to canine interleukin-4 receptor alpha202411,680,097Antibodies against canine PD-1202311,447,561PD-L1 antibodies binding canine PD-L1202211,248,047Caninized antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to INTERVET INC (10)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTERVET INC | 10 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |